TickerFactsScreenerDevelopers

Xeris Biopharma Holdings, Inc. (XERS) — Operating Income

Annual figures by fiscal year, from SEC filings.

2020: -$83.55M2021: -$115.16M2022: -$81.94M2023: -$44.01M2024: -$33.65M2025: $24.90M$24.90M
2020Operating Income (USD)2025
Fiscal YearOperating IncomeChange YoY
2025$24.90M+174.0%
2024-$33.65M+23.5%
2023-$44.01M+46.3%
2022-$81.94M+28.8%
2021-$115.16M-37.8%
2020-$83.55M—